A Study of Filgotinib 200 mg in Korean Participants With Moderately to Severely Active Ulcerative Colitis Under Routine Clinical Practice
Clinical trial NCT06964113 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06964113
- Sponsor
- Eisai Korea Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-11
- Primary completion
- 2027-11-30
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.